Apolipoprotein E knockout mice as a model of behavioral dysfunction Illana Gozes Editorial Article Pages: 149 - 150
Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer’s disease Lorenzo M. RefoloHoward M. Fillit Original Article Pages: 151 - 155
APOE genotype effects on alzheimer’s disease onset and epidemiology J. Wesson Ashford Original Article Pages: 157 - 165
Apolipoprotein E is a prime suspect, not just an accomplice, in Alzheimer’s disease Keith A. Crutcher Original Article Pages: 181 - 188
A dual role for apolipoprotein E in neuroinflammation Ling GuoMary Jo LaDuLinda J. Van Eldik Original Article Pages: 205 - 212
Insulin-degrading enzyme, apolipoprotein E, and Alzheimer’s disease Steven D. Edland Original Article Pages: 213 - 217
Cholesterol efflux as a critical component of Alzheimer’s disease pathogenesis G. William Rebeck Original Article Pages: 219 - 224
Apolipoprotein E as a target for developing new therapeutics for Alzheimer’s disease based on studies from protein, RNA, and regulatory region of the gene Debomoy K. Lahiri Original Article Pages: 225 - 233
ApoE and Aβ1–42 interactions Arlene M. ManelliW. Blaine StineMary Jo LaDu Original Article Pages: 235 - 246
In vivo effects of apoE and clusterin on amyloid-β metabolism and neuropathology David M. Holtzman Original Article Pages: 247 - 254
Apolipoprotein E dose-dependent modulation of β-amyloid deposition in a transgenic mouse model of Alzheimer’s disease Ronald B. DeMattos Original Article Pages: 255 - 262
